Mechanism of interaction of hypoglycemic agents glimepiride and glipizide with human serum albumin

• Authors: Neelam Seedher , Mamta Kanojia
• Languages of publication: EN

Abstracts

EN

The mechanism of interaction of hypoglycemic drugs, glimepiride and glipizide with human serum albumin (HSA) has been studied using fluorescence spectroscopy. The results are discussed in terms of the binding parameters, thermodynamics of the binding process, nature of forces involved in the interaction, identification of drug binding site on serum albumin and the fluorescence quenching mechanism involved. The association constants were of the order of 105 and glipizide was found to have much higher affinity for HSA than glimepiride at all temperatures. Thermodynamic parameters for the binding suggested that hydrophobic interactions are primarily involved in the binding of these drugs to HSA. However, glimepiride and glipizide appear to cause temperature-dependent conformational changes in the albumin molecule and, therefore, the nature of interaction varied with temperature. Glimepiride and glipizide bind to both site I and site II on HSA, but the primary interaction occurs at site II. The binding region in site II is different for the two drugs. Stern-Volmer analysis of quenching data indicated that tryptophan residues of HSA are not fully accessible to the drugs and a predominantly dynamic quenching mechanism is involved in the binding. Results can provide useful insight into prediction of competitive displacement of these drugs by other co-administered drugs and excipients, resulting in serious fluctuations of the blood glucose levels in diabetic patients. [...]

Keywords

EN

Binding; Fluorescence; Glimepiride; Glipizide; HSA

• Publisher: De Gruyter Open
• Journal: Open Chemistry
• Year: 2009
• Volume: 7
• Issue: 1
• Pages: 96-104

Dates

published

1 - 3 - 2009

online

23 - 12 - 2008

Contributors

author

Neelam Seedher

• Department of Chemistry, Panjab University, Chandigarh, 160014, India

author

Mamta Kanojia

• Department of Chemistry, Panjab University, Chandigarh, 160014, India

References

• [1] U. Kragh-Hansen, V.T.G. Chuang, M. Otagiri, Biol. Pharm. Bull. 25, 695 (2002) http://dx.doi.org/10.1248/bpb.25.695[Crossref]
• [2] C. Bertucci, E. Domenici, Curr. Med. Chem. 9, 1463 (2002)
• [3] U. Kragh-Hansen, Pharmacol. Rev. 33, 17 (1981)
• [4] P. Hsu, J.K.H. Ma, L.A. Luzzi, J. Pharm. Sci. 63, 570 (1974) http://dx.doi.org/10.1002/jps.2600630416[Crossref]
• [5] T. Izumi, Biopharm. Drug Disp. 18, 241 (1997) http://dx.doi.org/10.1002/(SICI)1099-081X(199704)18:3<241::AID-BDD17>3.0.CO;2-O[Crossref]
• [6] H. Gao, L.D. Lei, J.Q. Liu, Q. Kong, X.G. Chen, Z.D. Hu, J. Photochem. Photobiol. A: Chem. 167, 213 (2004) http://dx.doi.org/10.1016/j.jphotochem.2004.05.017[Crossref]
• [7] N. Zhou, Y. Liang, P. Wang, J. Mol. Struc. 872, 190 (2008) http://dx.doi.org/10.1016/j.molstruc.2007.02.035[Crossref]
• [8] A. Sulkowska, M. Maciazek-Jurczyk, B. Bojko, J. Rownicka, I. Zubik-Skupien, E. Temba, D. Pentak, W.W. Sulkowski, J. Mol. Struc. 881, 97 (2008) http://dx.doi.org/10.1016/j.molstruc.2007.09.001[Crossref]
• [9] M.H. Rahman, T. Maruyama, T. Okada, K. Yamasaki, M. Otagiri, Biochem Pharmacol 46, 1721 (1993) http://dx.doi.org/10.1016/0006-2952(93)90576-I[Crossref]
• [10] G. Weber, L.B. Young, J Biol. Chem. 239, 1415 (1964)
• [11] T. Maruyama, M. Otagiri, S.G. Schulman, Int. J. Pharm. 59, 137 (1990) http://dx.doi.org/10.1016/0378-5173(90)90088-L[Crossref]
• [12] L.D. Ward, Methods Enzymol. 117, 400 (1985) http://dx.doi.org/10.1016/S0076-6879(85)17024-2[Crossref]
• [13] B.K. Martin, Nature 207, 274 (1965) http://dx.doi.org/10.1038/207274a0[Crossref]
• [14] S. Jamzad, R. Fassihi, AAPS PharmSciTech. 7, E17 (2006) http://dx.doi.org/10.1208/pt070233[Crossref]
• [15] J. Kang, Y. Liu, M. Xie, S. Li, M. Jiang, Y. Wang, Biochim. Biophys. Acta 1674, 205 (2004)
• [16] B. Kljnert, L. Stainislawska, M. Bryszewska, B. Palecz, Biochim. Biophys. Acta 1648, 115 (2003)
• [17] W. Zhong, Y. Wang, J. Yu, Y. Liang, K. Ni, S. Tu, J. Pharm. Sci. 93, 1039 (2004) http://dx.doi.org/10.1002/jps.20005[Crossref]
• [18] H. Zia, J.C. Price, J. Pharm. Sci. 64, 1177 (1975) http://dx.doi.org/10.1002/jps.2600640710[Crossref]
• [19] E.J. Lien, P.H. Wang, J. Pharm. Sci. 69, 648 (1980) http://dx.doi.org/10.1002/jps.2600690610[Crossref]
• [20] D. Silva, C.M. Cortez, R.W. Louro, Spectrochimica Acta Part A 60, 1215 (2004) http://dx.doi.org/10.1016/j.saa.2003.08.003[Crossref]
• [21] Y.H. Pang, L.L. Yang, S.M. Shuang, C. Dong, M. Thompson, J. Photochem. Photobiol. B: Biology 80, 139 (2005) http://dx.doi.org/10.1016/j.jphotobiol.2005.03.006[Crossref]
• [22] W. He, Y. Li, C. Xue, Z. Hu, X. Chen, F. Sheng, Bioorg. Med. Chem. 13, 1837 (2005) http://dx.doi.org/10.1016/j.bmc.2004.11.038[Crossref]
• [23] P.D. Ross, S. Subramanian, Biochemistry 20, 3096 (1981) http://dx.doi.org/10.1021/bi00514a017[Crossref]
• [24] A. Sulkowska, B. Bojko, J. Rownicka, W.W. Sulkowski, J. Mol. Struc. 792, 249 (2006) http://dx.doi.org/10.1016/j.molstruc.2006.01.002[Crossref]
• [25] H.W. Jun, P.C. Ruenitz, J. Pharm. Sci. 67, 861 (1978) http://dx.doi.org/10.1002/jps.2600670637[Crossref]
• [26] A.E.A. Thumser, A.G. Buckland, D.C. Wilton, J. Lipid Res. 39, 1033 (1998)
• [27] G. Sudlow, D. Birkett, D. Wade, Mol. Pharmacol. 11, 824 (1975)
• [28] B. Nerli, D. Romanini, G. Pico, Chemico-Biological Interact. 104, 179 (1997) http://dx.doi.org/10.1016/S0009-2797(97)00024-0[Crossref]
• [29] S. Sugio, A. Kashima, S. Mochizuki, M. Noda, K. Kobayashi, Protein Eng. 12, 439 (1999) http://dx.doi.org/10.1093/protein/12.6.439[Crossref]
• [30] X.M. He, D.C. Carter, Nature 358, 209 (1992) http://dx.doi.org/10.1038/358209a0[Crossref]
• [31] M.R. Eftink, C.A. Ghiron, Anal. Biochem. 114, 199 (1981) http://dx.doi.org/10.1016/0003-2697(81)90474-7[Crossref]
• [32] P. Midoux, P. Wahl, J. Auchet, M. Monsigny, Biochim. Biophys. Acta 801, 16 (1984)

Identifiers

DOI

10.2478/s11532-008-0080-x